LON:PRTC PureTech Health (PRTC) Share Price, News & Analysis → They said crypto was dead. It went up 100X. (From InvestorPlace) (Ad) Free PRTC Stock Alerts GBX 221.50 +17.50 (+8.58%) (As of 12:44 PM ET) Add Compare Share Share Today's Range 212▼ 224.5050-Day Range 181▼ 213.5052-Week Range 139▼ 242.93Volume563,283 shsAverage Volume376,734 shsMarket Capitalization£597.94 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades Get PureTech Health alerts: Email Address Ad Paradigm Press8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)THIS cryptocurrency has gained 40% in 6 months. A crypto millionaire who has researched the space for a decade says it will go up 8,788% in 5 years. The name of this cryptocurrency is revealed right here: Click to get the name of the cryptocurrency About PureTech Health Stock (LON:PRTC)PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia. In addition, the company is developing drug delivery platform for oral administration of proteins, peptides, and other difficult-to-deliver payloads; products to generate new human hair follicles and hair; drug delivery platform for drugs that treat inflammation and associated disorders; platform to address immunosenescence; novel targeted immunotherapies for cancer; monoclonal antibodies for immuno-suppressive gamma delta T cells in pancreatic and colorectal cancers, and other solid tumors; novel approaches to enhance delivery and distribution of therapeutics; and digital health technologies, as well as engages in enhancing health through food through the creation of nutrition technology. Further, it is developing a platform and products that take in physiological data from sensors and correlates that data with musical data components; voice-based tools for passive assessment and tracking of patient health; commensal organism-based products for enhancing human health; and technology platform to identify experts in healthcare and other research-based disciplines, as well as engages in identifying healthcare expert networks and reviewing their conversations and content on social media. The company was incorporated in 2015 and is based in Boston, Massachusetts.Read More PRTC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PRTC Stock News HeadlinesFebruary 28, 2024 | finance.yahoo.comAKLI Mar 2024 1.000 callFebruary 8, 2024 | msn.com2 impressive growth stocks I’ve got my eye on in FebruaryMarch 19, 2024 | Colonial Metals (Ad)Central Bank Gold Heist In ProgressWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.November 17, 2023 | finance.yahoo.comPureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in SchizophreniaNovember 14, 2023 | lse.co.ukPureTech Health celebrates positive results in Phase 2 anxiety trialNovember 14, 2023 | finance.yahoo.comPureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy VolunteersAugust 29, 2023 | finanznachrichten.dePureTech Health plc - Half-Year ReportAugust 1, 2023 | msn.comPureTech bags $11.4M from U.S. Department of Defense contractMarch 19, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.August 1, 2023 | finance.yahoo.comPureTech Awarded up to $11.4 Million from U.S. Department of Defense to Advance LYT-300 (Oral Allopregnanolone) for Fragile X-associated Tremor/Ataxia SyndromeJune 21, 2023 | lse.co.ukPureTech Health launches next stage of anxiety disorder drug trialJune 21, 2023 | finance.yahoo.comPureTech Initiates Phase 2a Clinical Trial of LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety DisordersApril 29, 2023 | benzinga.comPureTech Health Stock (NASDAQ:PRTC), DividendsApril 28, 2023 | markets.businessinsider.comPureTech Health FY22 Revenue Declines 10.2% YoY, Here Are The DetailsApril 25, 2023 | bizjournals.comMicrobiome-focused PureTech spinout raises $106.5M to fund two trialsApril 25, 2023 | finance.yahoo.comPureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia TherapiesApril 20, 2023 | lse.co.ukPureTech Health's Vedanta Biosciences boasts "promising" resultsMarch 23, 2023 | proactiveinvestors.comPureTech Health remains undervalued after KarXCT deal, says brokerMarch 23, 2023 | marketwatch.comPureTech Health Shares Rise on Schizophrenia Treatment Candidate Royalty DealMarch 23, 2023 | markets.businessinsider.comRoyalty Pharma Acquires Interest In PureTech's Royalty In Karuna Therapeutics' KarXTMarch 23, 2023 | proactiveinvestors.comPureTech Health shares jump 10% on US$500mln royalty dealMarch 23, 2023 | finance.yahoo.comRoyalty Pharma and PureTech Health Enter Into KarXT Royalty Agreement for Up to $500 MillionFebruary 27, 2023 | finance.yahoo.comPureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD)December 19, 2022 | marketwatch.comPureTech Health's Depression Treatment Phase 1 Study Shows Positive DataDecember 13, 2022 | finance.yahoo.comPureTech to Present at 41st Annual J.P. Morgan Healthcare ConferenceDecember 12, 2022 | finance.yahoo.comPureTech Presents Data for LYT-200 Targeting Galectin-9 in Preclinical Leukemia Cancer Models at the 64th American Society of Hematology (ASH) Annual MeetingDecember 9, 2022 | finance.yahoo.comPureTech Founded Entity Sonde Health Raises $19.25 Million Series B for Voice-Based Health MonitoringSee More Headlines Receive PRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PureTech Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:PRTC CUSIPN/A CIKN/A Webpuretechhealth.com Phone+1-617-4822333FaxN/AEmployees300Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-47,010,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-7.22% Return on Assets-14.24% Debt Debt-to-Equity Ratio25.41 Current Ratio7.31 Quick Ratio2.51 Sales & Book Value Annual Sales£11.74 million Price / Sales50.93 Cash FlowGBX 103.42 per share Price / Cash Flow2.14 Book ValueGBX 186 per share Price / Book1.19Miscellaneous Outstanding Shares269,950,000Free FloatN/AMarket Cap£597.94 million OptionableNot Optionable Beta0.94 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMs. Daphne Zohar (Age 47)Founder, CEO & Exec. Director Dr. Bennett M. Shapiro (Age 78)Co-Founder & Non-Exec. Director Dr. Robert S. Langer Jr. (Age 69)Co-Founder, Non-Exec. Director & Member of Scientific Advisory Board Mr. Stephen M. Muniz J.D. (Age 48)COO, Exec. VP of Legal & Operations, Sec. and Exec. Director Dr. Bharatt M. Chowrira (Age 53)Pres and Chief of Bus. & Strategy Key CompetitorsSilence TherapeuticsLON:SLNErgomedLON:ERGOHorizon Discovery Group plc (HZD.L)LON:HZDBioventixLON:BVXPVerona Pharma plc (VRP.L)LON:VRPView All Competitors PRTC Stock Analysis - Frequently Asked Questions How have PRTC shares performed in 2024? PureTech Health's stock was trading at GBX 194.20 at the start of the year. Since then, PRTC stock has increased by 14.1% and is now trading at GBX 221.50. View the best growth stocks for 2024 here. What other stocks do shareholders of PureTech Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other PureTech Health investors own include Nemaska Lithium (NMX), Yamana Gold (YRI), Asanko Gold (AKG), Arotech (ARTX), Boeing (BA), Baozun (BZUN), Chaarat Gold (CGH), Eldorado Gold (ELD), CarMax (KMX) and Knowles (KN). How do I buy shares of PureTech Health? Shares of PRTC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:PRTC) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThe world’s greatest investmentPorter & CompanySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders Agency Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.